Maravai LifeSciences Inc... (MRVI)
NASDAQ: MRVI
· Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:59 PM
2.62
0.19%
After-hours: Aug 15, 2025, 06:49 PM EDT
Maravai LifeSciences Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 215.85M | 241.86M | 259.19M | 276.92M | 278.58M | 274.1M | 288.94M | 419.52M | 543.91M | 717.73M | 883M | 906.73M | 920.28M | 895.32M | 799.24M | 669.15M | 552.2M | 381.33M |
Cost of Revenue | 153.02M | 151.67M | 157.75M | 156.01M | 155.87M | 160.87M | 149.34M | 166.89M | 168.38M | 162.6M | 168.96M | 154.84M | 148.71M | 148.73M | 139.07M | 123.32M | 111.04M | 94.72M |
Gross Profit | 62.83M | 90.19M | 101.44M | 120.91M | 122.72M | 113.23M | 139.6M | 252.63M | 375.54M | 555.13M | 714.04M | 751.89M | 771.57M | 746.59M | 660.17M | 545.83M | 441.16M | 286.61M |
Operating Income | -322.68M | -265.92M | -235.62M | -197.27M | -43.58M | -45.68M | -28.98M | 80.05M | 212.37M | 404.69M | 574.22M | 619.51M | 659.48M | 633.02M | 558.1M | 434.81M | 323.65M | 177.53M |
Interest Income | 19.36M | 23.42M | 27.4M | 28.83M | 29.19M | 28.89M | 27.73M | 22.61M | 15.17M | 8.38M | 2.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -348.96M | -291.76M | -261.48M | 441.21M | 596.29M | 599.85M | 617.74M | 57.43M | 191.75M | 380.11M | 551.47M | 600.28M | 638.17M | 608.91M | 531.63M | 401.78M | 288.8M | 143.74M |
Net Income | -194.72M | -162.71M | -144.85M | -224.66M | -132.08M | -131.04M | -120.31M | 73.08M | 179.19M | 342.45M | 490.66M | 459.06M | 413.69M | 306.04M | 182.43M | 151.81M | 136.48M | 87.61M |
Selling & General & Admin | 158.47M | 160.45M | 152.08M | 144.47M | 144.24M | 139.06M | 146.54M | 150.12M | 142.05M | 134.73M | 129.26M | 117.64M | 112.03M | 108.06M | 98.09M | 114.13M | 109.45M | 101.36M |
Research & Development | 18.68M | 19.08M | 19.22M | 19.25M | 19.26M | 18.17M | 17.28M | 17.7M | 18.74M | 18.82M | 18.37M | 22.54M | 19.1M | 16.76M | 15.23M | 8.14M | 8.06M | 7.72M |
Other Expenses | 208.37M | 176.58M | 164.15M | 152.86M | 1.19M | 2.38M | 2.55M | 2.55M | 164K | 164K | 3K | 204K | 286K | 283K | 279K | 78K | 32K | 55K |
Operating Expenses | 385.51M | 356.11M | 335.45M | 316.58M | 164.69M | 159.62M | 166.2M | 170.2M | 160.78M | 153.55M | 147.63M | 140.18M | 131.13M | 124.82M | 113.32M | 122.27M | 117.51M | 109.08M |
Interest Expense | 38.49M | 43.61M | 47.7M | 51.84M | 49.84M | 44.92M | 45.89M | 40.67M | 32.17M | 29.58M | 20.41M | 17.26M | 21.8M | 25.02M | 30.26M | 32.04M | 31.45M | 31.26M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 538.54M | 507.77M | 494.8M | 474.19M | 322.16M | 322.09M | 315.55M | 337.08M | 329.16M | 316.15M | 316.58M | 295.02M | 279.85M | 273.55M | 252.39M | 245.59M | 228.54M | 203.8M |
Income Tax Expense | -3.82M | -1.97M | -1.86M | 764.32M | 758.54M | 759.56M | 756.11M | -1.61M | 17.96M | 37.65M | 60.81M | 69.94M | 74.67M | 67.79M | 61.52M | 44.31M | 25.11M | 12.95M |
Shares Outstanding (Basic) | 144.24M | 143.43M | 141.81M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M | 131.74M | 131.63M | 131.54M | 131.5M | 131.5M | 131.46M | 118.43M | 112.2M | 96.65M |
Shares Outstanding (Diluted) | 144.24M | 143.43M | 139.73M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M | 131.74M | 131.65M | 131.65M | 121.97M | 121.97M | 121.97M | 121.97M | 112.28M | 96.67M |
EPS (Basic) | -1.36 | -1.15 | -1.03 | -1.65 | -1 | -0.99 | -0.91 | 0.55 | 1.36 | 2.60 | 3.73 | 3.49 | 3.19 | 2.44 | 1.56 | 1.40 | 1.38 | 0.94 |
EPS (Diluted) | -1.36 | -1.15 | -1.03 | -1.65 | -1 | -0.99 | -0.91 | 0.55 | 1.36 | 2.69 | 3.90 | 3.66 | 3.34 | 2.50 | 1.54 | 1.34 | 1.34 | 0.90 |
EBITDA | -284.12M | -208.29M | -156.92M | 548.36M | 700.5M | 696.4M | 712.41M | 141.99M | 264.63M | 447.5M | 608.05M | 651.01M | 691.48M | 664.72M | 591.19M | 471.25M | 356.4M | 209.43M |
EBIT | -310.47M | -248.15M | -213.78M | 493.04M | 646.13M | 644.77M | 658.85M | 93.32M | 219.15M | 404.91M | 571.89M | 614.09M | 657.38M | 632.2M | 561.02M | 436.42M | 321.94M | 175.84M |
Depreciation & Amortization | 43.48M | 58.02M | 56.87M | 55.32M | 54.38M | 51.63M | 48.78M | 44M | 40.81M | 37.92M | 36.27M | 33.47M | 30.64M | 29.07M | 26.71M | 27.23M | 26.83M | 25.96M |